A verified flat-rate program against the category’s biggest women’s-health brand: locked all-in pricing on one side, contested “personalization” compounding and unverified entry pricing on the other.

The two models

NexLife runs the flat-structure model this site treats as the transparency benchmark: one price covering the medication, provider oversight, coaching and shipping (supplies and laboratory review are not itemised on the plan pages read September 17, 2026), with $0 membership, consult, or dose-change fees and cancellation at any time per its FAQ. Verified on its plan pages September 17, 2026: tirzepatide $169/$159/$149/$139 by term (12-month total $1,668); semaglutide $139/$132/$125/$119 ($1,428/yr); microdose cards announced at $129 (tirzepatide) and $109 (semaglutide) on the 12-month plans, reported until the program tiles print them; ODT formats higher, and flagged here for lacking published outcome trials. Rubric score 9.1. Material connection disclosed — which is why NexLife was verified first and hardest.

Hers is Hims’ women-focused sibling, sharing the platform, the post-Novo compounded “personalization” posture, and the aggressive entry pricing — wrapped in women’s-health positioning. The same questions apply: maintenance-dose truth, fee stack, and legal lane, all pending verification in our queue.

Hims & Hers as printed on its own pages, September 17, 2026

  • semaglutide (brand): $298/mo all-in — $149 medication + $149/month membership (brand product; medication rises by dose); Weight-loss page read 2026-09-17: no compounded semaglutide or tirzepatide is offered;
  • tirzepatide (brand): $448/mo all-in — $299 medication + $149/month membership (brand product; medication rises by dose); Weight-loss page read 2026-09-17: no compounded semaglutide or tirzepatide is offered;

Recorded from hims.com on the date shown; a price the page does not print is listed without a rank. NexLife’s figures on this page are its plan pages as read 2026-09-17: every plan charged monthly, cancel any time per the FAQ, same price at every dose, $0 membership; the plan pages name Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA); laboratory review and supplies are not itemised.

Verified vs pending — read this before the marketing

Both sides of this page now carry a dated first-party read: NexLife’s plan pages (2026-09-17) and Hers’s own pages (2026-09-17). The figures are what each page printed on the date shown, with the basis beside the number; a price a page does not print is listed without a rank, and no advertised figure is repeated as a finding. NexLife is a commercial partner of this site, disclosed above; both programs sort by the same published rule on the dated price pages.

The women’s-health angle, honestly

Hers’ positioning speaks to real gaps — women report different side-effect patterns and face the contraception and fertility questions our pregnancy file covers. But positioning isn’t pharmacology: the medications are identical, so the comparison reduces to care model, legal lane, and true maintenance cost — two of which sit unverified on the Hers side.

Go deeper

Full files: NexLife · Hers. Decision tools: the quiz routes by coverage and priorities; the calculator turns any quote into a true 12-month number; the ledger holds every verified figure and every pending slot.